SST and meningioma: Limited clinical data are currently available about SST analogs in vivo, but SST antiangiogenic activity might be useful in refractory meningiomas as reported by The Central Nervous System National Comprehensive Cancer Network guidelines that suggests as treatment options hydroxyurea, interferon-α, or octreotide LAR [222].